UC San Diego Moores Cancer Center 19th Industry/Academia Next-Generation Precision Oncology Symposium to be held on April 27
Retrieved on:
Thursday, April 20, 2023
Oncology, Education, Health, Research, Science, University, Office of Industrial Relations, Bevacizumab, UCL, Drug development, MBBS, Senior, Research fellow, Mirati Therapeutics, New product development, Alexandria Boehm, Therapy, UC San Diego Health, Symposium (Plato), Genomics, Doctor of Philosophy, Cancer, UC, MD, Patient, Symposium, Cell, Knowledge, Moores Cancer Center, Foundation Medicine, Roswell Park Comprehensive Cancer Center, Conference, Pharmaceutical industry, Genentech, Discovery, Pediatric nursing
Moores Cancer Center at UC San Diego Health and the Office of Industry Relations today announced that the 19th annual Industry/Academia Next Generation Precision Oncology Symposium will be held Thursday, April 27, at The Alexandria at Torrey Pines Conference Center.
Key Points:
- Moores Cancer Center at UC San Diego Health and the Office of Industry Relations today announced that the 19th annual Industry/Academia Next Generation Precision Oncology Symposium will be held Thursday, April 27, at The Alexandria at Torrey Pines Conference Center.
- As part of the event, Napoleone Ferrara, MD, Distinguished Professor, Senior Deputy Director for Basic Sciences, Moores Cancer Center, will be honored as the 2023 Duane Roth Achievement Award recipient.
- “The symposium is a unique forum uniting life science innovators from around the world to brainstorm translational oncology research,” said Ida Deichaite, Ph.D., director of UC San Diego Moores Cancer Center’s Office of Industry Relations and an organizer of the symposium.
- Talks presented at the symposium include:
Presentations by researchers from oncology companies, including Cardiff Oncology, eFFECTOR Therapeutics, Hoffman-La Roche and Genentech, Kura Oncology, Mirati Therapeutics, Payclex, Poseida Therapeutics, and Shoreline Biosciences